RSC Medicinal Chemistry · 2022 · 18 citations · 44 references
Life SciencesBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyAmyloid FormationLigand BindingMetal-ligand BondingNanomedicinePeptidomimetic DesignProtein AggregationAggregation InhibitorsAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid FibrillogenesisAmyloid ToxicityCyclic Peptide DesignCyclic PeptidesCyclic Peptidomimetics
, thereby exhibiting profound selectivity, probed using UV-visible spectroscopy, thioflavin T (ThT) fluorescence assay, tyrosine (TYR10) fluorescence assay, isothermal titration calorimetry (ITC) and transmission electron microscopy (TEM). The non-toxicity of the designed peptidomimetics and their ability to reduce aggregating Aβ-fragment induced cytotoxicity was confirmed by the MTT assay on the mouse neuronal cell line. Further, the molecular interaction between the peptidomimetics and the Aβ-fragment was confirmed by Förster resonance energy transfer (FRET) studies using fluorescently labeled analogs. Cytotoxicity and cell internalization were also confirmed. A preliminary mechanistic investigation indicates that the peptidomimetic works by a synergistic effect of conformational restriction and metal sequestration. Such peptidomimetics can shed light on the mechanism of aggregation and a novel therapeutic approach.
44
Copper, iron and zinc in Alzheimer's disease senile plaques
Mark A. Lovell, J. David Robertson, W.J. Teesdale et al. · Journal of the Neurological Sciences · 1998 · 2.1K citations
Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand
Lars O. Tjernberg, Jan Näslund, Fredrik Lindqvist et al. · Journal of Biological Chemistry · 1996 · 948 citations · Full text